[Clinical effect of beta receptor blockader in angina pectoris caused by coronary sclerosis].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy*; D001776:Blood Circulation Time; D003327:Coronary Disease / Q000188:drug therapy; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010101:Oxygen Consumption; D011433:Propranolol / Q000008:administration & dosage / Q000009:adverse effects; D013565:Sympatholytics / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D013565:Sympatholytics; D011433:Propranolol
Die klinische Wirkung der  -Rezeptorenblaocker bei koronarsklerotisch bedingter Angina pectoris.